 comparison chlorambucil prednison versu cyclophosphamid vincristin prednison initi treatment chronic lymphocyt leukemia long-term follow-up eastern cooper oncolog group clinic trial eastern cooper oncolog group ecog studi patient advanc chronic lymphocyt leukemia cll regimen chlorambucil day prednison mg day week intens regimen cyclosphosphamid day vincristin IV day prednison day cvp week treatment month maxim respons elig patient cvp median follow-up year signific differ surviv year complet remiss CR rate durat respons year cvp toxic modest prolong treatment long median surviv year stage iii IV patient superior treatment respons increas intens therapi result compar cyclophosphamid doxorubicin vincristin prednison chop therapi investig data suggest intermitt respons standard treatment approach advanc cll